Medtronic launches new heart valve repair ring worldwide
This article was originally published in Clinica
Medtronic has launched the Contour 3D annuloplasty ring, intended for the treatment of tricuspid valve disease, worldwide. It is approved in the US, Europe and several other countries. The ring is designed to treat tricuspid dilation, a progressive disease that leads to severe tricuspid regurgitation, which occurs when the tricuspid valve leaflets do not close properly, allowing blood to flow opposite of the intended direction. The Contour 3D is implanted surgically to restore normal valve function by remodelling the natural valve’s shape and size.